Purchases and Sales Made in Q3 2024 in Sc Pharmaceuticals Inc. (SCPH)
This table provides information about the institutional ownership of Sc Pharmaceuticals Inc. (SCPH) during Q3 2024. The information is specifically focused on institutions that hold shares of scPharmaceuticals Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
276+ 10.31% |
$1.14K - $1.52K
|
2.95K
$9.72K
|
|
|
Oct 04, 2024
Q3 2024
|
Gamma Investing LLC
Foster City, CA |
BUY
|
- |
164+ 162.38% |
$676 - $904
|
265
$872
|
|
|
Nov 01, 2024
Q3 2024
|
Covestor LTD
Boston, MA |
BUY
|
- |
151New |
$622 - $832
|
151
$497
|
|
|
Nov 01, 2024
Q3 2024
|
Capital Performance Advisors LLP
|
BUY
|
- |
85New |
$350 - $468
|
85
$280
|
|
|
Nov 12, 2024
Q3 2024
|
Sterling Capital Management LLC
Charlotte, NC |
BUY
|
- |
29New |
$119 - $160
|
29
$95.4
|
|
|
Oct 24, 2024
Q3 2024
|
Nisa Investment Advisors, LLC
|
BUY
|
- |
4+ 2.78% |
$16.5 - $22
|
148
$487
|
|
|
Oct 10, 2024
Q3 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2024
Q3 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-112- 0.97% |
$461 - $617
|
11.4K
$37.5K
|
|
|
Feb 07, 2025
Q3 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-112- 0.97% |
$461 - $617
|
11.4K
$37.5K
|
|
|
Nov 13, 2024
Q3 2024
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-347- 3.82% |
$1.43K - $1.91K
|
8.74K
$28.8K
|
|
|
Dec 26, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-444- 3.47% |
$1.83K - $2.45K
|
12.3K
$40.6K
|
|
|
Nov 08, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-444- 3.47% |
$1.83K - $2.45K
|
12.3K
$40.6K
|
|
|
Nov 07, 2024
Q3 2024
|
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
|
SELL
|
- |
-650- 3.52% |
$2.68K - $3.58K
|
17.8K
$58.7K
|
|
|
Nov 12, 2024
Q3 2024
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-1.12K- 4.93% |
$4.6K - $6.15K
|
21.5K
$70.9K
|
|
|
Nov 14, 2024
Q3 2024
|
Pdt Partners, LLC
New York, NY |
SELL
|
- |
-2.19K- 12.6% |
$9.01K - $12.1K
|
15.2K
$49.9K
|
|
|
Oct 31, 2024
Q3 2024
|
Perkins Capital Management Inc
|
SELL
|
- |
-2.2K- 11.96% |
$9.06K - $12.1K
|
16.2K
$53.3K
|
|
|
Nov 12, 2024
Q3 2024
|
Rhumbline Advisers
Boston, MA |
SELL
|
- |
-2.49K- 6.56% |
$10.3K - $13.7K
|
35.4K
$117K
|
|
|
Nov 14, 2024
Q3 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-3.14K- 44.08% |
$12.9K - $17.3K
|
3.99K
$13.1K
|
|
|
Nov 12, 2024
Q3 2024
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-3.31K- 4.18% |
$13.6K - $18.2K
|
75.9K
$250K
|
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-5.17K- 21.6% |
$21.3K - $28.5K
|
18.8K
$61.7K
|
|
|
Oct 18, 2024
Q3 2024
|
Raymond James & Associates
St Petersburg, FL |
SELL
|
- |
-5.35K- 6.22% |
$22.1K - $29.5K
|
80.7K
$266K
|
|
|
Nov 14, 2024
Q3 2024
|
Sherbrooke Park Advisers LLC
White Plains, NY |
SELL
|
- |
-13.7K- 47.23% |
$56.6K - $75.7K
|
15.3K
$50.5K
|
|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-20.2K- 46.25% |
$83.2K - $111K
|
23.5K
$77.3K
|
|
|
Nov 14, 2024
Q3 2024
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-49.1K- 25.98% |
$202K - $271K
|
140K
$460K
|
|
|
Nov 13, 2024
Q3 2024
|
Tejara Capital LTD
London, X0 |
SELL
|
- |
-54.5K- 7.73% |
$224K - $300K
|
650K
$2.14M
|
|
|
Nov 07, 2024
Q3 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-102K- 75.46% |
$420K - $562K
|
33.2K
$109K
|
|
|
Nov 13, 2024
Q3 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-162K- 73.46% |
$669K - $895K
|
58.7K
$193K
|
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-209K- 28.48% |
$863K - $1.15M
|
526K
$1.73M
|